金山科研平台，产品价格货期咨询微信：jinshanbio Source:Mouse myeloma cell line, NS0-derived Accession #:Q08334 N-terminal Sequence Analysis:Met20 Structure:Disulfide-linked homodimer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:51 kDa (monomer) SDS-PAGE:75-85 kDa, reducing conditions Activity:Measured by its binding ability in a functional ELISA.When Recombinant Human IL‑28R alpha/IFN‑lambda R1 Fc Chimera (Catalog# 5260-MR) is immobilized at0.5µg/well, the concentration of Recombinant Human IL-10 R beta FcChimera that produces 50% of the optimal binding response is found to be approximately 4-16 µg/mL. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: IL-10 R beta Long Name: Interleukin 10 Receptor beta Aliases: CDw210b; CRFB4; D21S58; IL-10R2; IL10RB Entrez Gene IDs: 3588 (Human); 16155 (Mouse) Background: IL-10 R beta IL-10 mediates its biological activities via binding to a heteromeric complex of two distinct type II cytokine receptor subunits, the ligand binding subunit IL-10 R alpha (IL-10 R1) and the signal-transducing accessory subunit IL-10 R beta (IL-10 R2). IL-10 R alpha is specific for IL-10 and expressed by most hemopoietic cells. IL-10 R beta is a widely expressed shared subunit for IL-10, IL-22, IL-26 and the IFNl proteins IL-28A, IL-28B and IL-29.